{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T12:22:52Z","timestamp":1786537372843,"version":"build-2736575974"},"reference-count":31,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Growing evidence suggests that the gut microbiota is involved in the initiation and progression of ankylosing spondylitis (AS). In this study, we aimed to explore the gut microbiome alterations during adalimumab therapy and verify microbiome biomarkers predicting treatment response. By evaluating the gut microbial features of 30 AS patients before and after adalimumab therapy for 6 months and 24 healthy controls, we confirmed that the microbiome was restored remarkably after 6 months of adalimumab therapy in AS patients. We then compared the baseline gut microbiome of 22 adalimumab responders with 8 non-responders, a higher abundance of <jats:italic>Comamonas<\/jats:italic> was revealed in the latter, although no statistical difference was found after adjusting for the false discovery rate. These results suggested that adalimumab therapy restored the gut microbiome in AS patients and indicated the utility of gut microbiome to be potential biomarkers for therapeutic evaluation. These findings provided an insight into the development of predictive tools and the establishment of precise medical interventions for clinical practice.<\/jats:p>","DOI":"10.3389\/fimmu.2021.700570","type":"journal-article","created":{"date-parts":[[2021,9,4]],"date-time":"2021-09-04T01:45:56Z","timestamp":1630719956000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":30,"title":["Adalimumab Therapy Restores the Gut Microbiota in Patients With Ankylosing Spondylitis"],"prefix":"10.3389","volume":"12","author":[{"given":"Zena","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuqi","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jialing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiujing","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linkai","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ou","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieruo","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,9,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1056\/nejmra1406182","article-title":"Ankylosing Spondylitis and Axial Spondyloarthritis","volume":"374","author":"Taurog","year":"2016","journal-title":"N Engl J Med"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.12688\/F1000RESEARCH.14956.1","article-title":"Recent Advances in Ankylosing Spondylitis: Understanding the Disease and Management [Version 1; Peer Review: 2 Approved]","volume":"7","author":"Garcia-Montoya","year":"2018","journal-title":"F1000Research"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2016.10.012","article-title":"Roles for Intestinal Bacteria, Viruses, and Fungi in Pathogenesis of Inflammatory Bowel Diseases and Therapeutic Approaches","volume":"152","author":"Sartor","year":"2017","journal-title":"Gastroenterology"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/S0198-8859(00)00122-1","article-title":"Germ-Free Mice do Not Develop Ankylosing Enthesopathy, a Spontaneous Joint Disease","volume":"61","author":"\u0158eh\u00e1kov\u00e1","year":"2000","journal-title":"Hum Immunol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1002\/art.39681","article-title":"Perturbed Mucosal Immunity and Dysbiosis Accompany Clinical Disease in a Rat Model of Spondyloarthritis","volume":"68","author":"Asquith","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1002\/art.39802","article-title":"Brief Report: Dialister as a Microbial Marker of Disease Activity in Spondyloarthritis","volume":"69","author":"Tito","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1002\/art.40917","article-title":"HLA Alleles Associated With Risk of Ankylosing Spondylitis and Rheumatoid Arthritis Influence the Gut Microbiome","volume":"71","author":"Asquith","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"5446","DOI":"10.1038\/s41598-018-23571-4","article-title":"Microbiota Composition May Predict Anti-TNF Alpha Response in Spondyloarthritis Patients: An Exploratory Study","volume":"8","author":"Bazin","year":"2018","journal-title":"Sci Rep"},{"key":"B9","doi-asserted-by":"publisher","first-page":"e927","DOI":"10.1002\/mbo3.927","article-title":"Anti-TNF-\u03b1 Therapy Alters the Gut Microbiota in Proteoglycan-Induced Ankylosing Spondylitis in Mice","volume":"8","author":"Liu","year":"2019","journal-title":"Microbiologyopen"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1002\/art.41042","article-title":"Update of the American College of Rheumatology\/Spondylitis Association of America\/Spondyloarthritis Research and Treatment Network Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis","volume":"71","author":"Ward","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjw051","article-title":"Anti-TNF Therapy Response in Patients With Ulcerative Colitis Is Associated With Colonic Antimicrobial Peptide Expression and Microbiota Composition","volume":"10","author":"Magnusson","year":"2016","journal-title":"J Crohn\u2019s Colitis"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1128\/msystems.00188-17","article-title":"Gut Microbiota Offers Universal Biomarkers Across Ethnicity in Inflammatory Bowel Disease Diagnosis and Infliximab Response Prediction","volume":"3","author":"Zhou","year":"2018","journal-title":"mSystems"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780270401","article-title":"Evaluation of Diagnostic Criteria for Ankylosing Spondylitis. A Proposal for Modification of the New York Criteria","volume":"27","author":"van der Linden","year":"1984","journal-title":"Arthritis Rheum"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2018-213184","article-title":"Ankylosing Spondylitis Disease Activity Score (ASDAS): 2018 Update of the Nomenclature for Disease Activity States","volume":"77","author":"Machado","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"B15","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1136\/ard.2010.138594","article-title":"Ankylosing Spondylitis Disease Activity Score (ASDAS): Defining Cut-Off Values for Disease Activity States and Improvement Scores","volume":"70","author":"MacHado","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-215763","article-title":"Shotgun Metagenomics Reveals an Enrichment of Potentially Cross-Reactive Bacterial Epitopes in Ankylosing Spondylitis Patients, as Well as the Effects of TNFi Therapy Upon Microbiome Composition","volume":"79","author":"Yin","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1128\/msystems.00009-15","article-title":"Improved Bacterial 16s rRNA Gene (V4 and V4-5) and Fungal Internal Transcribed Spacer Marker Gene Primers for Microbial Community Surveys","volume":"1","author":"Walters","year":"2016","journal-title":"mSystems"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1002\/9780471729259.mc01e05s27","article-title":"Using QIIME to Analyze 16s rRNA Gene Sequences From Microbial Communities","volume":"1","author":"Kuczynski","year":"2012","journal-title":"Curr Protoc Microbiol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkx295","article-title":"MicrobiomeAnalyst: A Web-Based Tool for Comprehensive Statistical, Visual and Meta-Analysis of Microbiome Data","volume":"45","author":"Dhariwal","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2699.2001.00563.x","article-title":"Scale and Species Richness: Towards a General, Hierarchical Theory of Species Diversity","volume":"28","author":"Whittaker","year":"2001","journal-title":"J Biogeogr"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/ismej.2010.133","article-title":"UniFrac: An Effective Distance Metric for Microbial Community Comparison","volume":"5","author":"Lozupone","year":"2011","journal-title":"ISME J"},{"key":"B22","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s13059-017-1271-6","article-title":"Quantitative Metagenomics Reveals Unique Gut Microbiome Biomarkers in Ankylosing Spondylitis","volume":"18","author":"Wen","year":"2017","journal-title":"Genome Biol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-211064","article-title":"Faecal Microbiota Study Reveals Specific Dysbiosis in Spondyloarthritis","volume":"76","author":"Breban","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"B24","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1038\/nm.3914","article-title":"The Oral and Gut Microbiomes Are Perturbed in Rheumatoid Arthritis and Partly Normalized After Treatment","volume":"21","author":"Zhang","year":"2015","journal-title":"Nat Med"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2019.00040","article-title":"Altered Gut Microbiota in Chinese Children With Autism Spectrum Disorders","volume":"9","author":"Ma","year":"2019","journal-title":"Front Cell Infect Microbiol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/1759720X20970028","article-title":"Depression in Patients With Spondyloarthritis: Prevalence, Incidence, Risk Factors, Mechanisms and Management","volume":"12","author":"Parkinson","year":"2020","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1002\/art.41622","article-title":"The Pre-Treatment Gut Microbiome Is Associated With Lack of Response to Methotrexate in New Onset Rheumatoid Arthritis","volume":"73","author":"Artacho","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2019.05.009","article-title":"Bringing Microbiome-Drug Interaction Research Into the Clinic","volume":"44","author":"Guthrie","year":"2019","journal-title":"EBioMedicine"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2019-320204","article-title":"Interaction Between Drugs and the Gut Microbiome","volume":"69","author":"Weersma","year":"2020","journal-title":"Gut"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000009296","article-title":"Comamonas Kerstersii Bacteremia in a Patient With Acute Perforated Appendicitis","volume":"97","author":"Zhou","year":"2018","journal-title":"Med (United States)"},{"key":"B31","doi-asserted-by":"publisher","first-page":"087","DOI":"10.4103\/jlp.jlp_116_18","article-title":"Bacteremia Caused by Comamonas Testosteroni an Unusual Pathogen","volume":"11","author":"Tiwari","year":"2019","journal-title":"J Lab Physicians"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.700570\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,4]],"date-time":"2021-09-04T01:46:02Z","timestamp":1630719962000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.700570\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,1]]},"references-count":31,"alternative-id":["10.3389\/fimmu.2021.700570"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2021.700570","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,1]]},"article-number":"700570"}}